Skip Navigation
Skip to contents



10 results

Pattern of Apoptosis by NS398, a Selective COX-2 Inhibitor, in Hepatocellular Carcinoma Cell Lines

Park MK, Kim MK, Kim JC, Sung YK

  • Cancer Res Treat.
  • 2005 Oct;37(5):313-317.
PURPOSE: NS398, a selective COX-2 inhibitor, is known to inhibit the growth of COX-2 expressing hepatocellular carcinoma cells. The present study investigated whether the cytotoxic effect of NS398 was COX-2...
Tetraarsenic Oxide-mediated Apoptosis in a Cervical Cancer Cell Line, SiHa

Kim J, Bae SM, Lim DS, Kwak SY, Lee CK, Lee YS, Bae IJ, Yoo JY, Lee YJ, Kim CK, Ahn WS

  • Cancer Res Treat.
  • 2005 Oct;37(5):307-312.
PURPOSE: Diarsenic oxide, As2O3, has been reported to be effective in treating acute leukemia, and induce apoptosis in many tumor cells. In this study, the ability of a novel arsenical...
Relationship between Pre-treatment Serum SCC (squamous cell carcinoma) Antigen, Cyfra 21-1 Levels, and Survival in Squamous Cell Carcinoma of the Uterine Cervix

Chang KH, Ryu HS, Chang SJ, Byun YJ, Lee JP

  • Cancer Res Treat.
  • 2005 Oct;37(5):302-306.
PURPOSE: To determine the relationship between pretreatment serum squamous cell carcinoma (SCC) antigen and Cyfra 21-1 levels, and survival in patients with invasive squamous cell carcinoma of the cervix. MATERIALS...
Prognostic Factors in Non-Hodgkin's Lymphoma Patients Treated by Autologous Stem Cell Transplantation: A Single Center Experience

Suh C, Kim SH, Kim HJ, Jang G, Kim EK, Ko OB, Kim S, Sohn HJ, Lee JS, Kim W, Huh J

  • Cancer Res Treat.
  • 2005 Oct;37(5):294-301.
PURPOSE: Autologous stem cell transplantation (ASCT) is increasingly used in patients with non-Hodgkin's lymphoma (NHL). Various clinical parameters-were evaluated to obtain significant predictors of the outcome following ASCT in patients...
Comparison of WHO and RECIST Criteria for Response in Metastatic Colorectal Carcinoma

Choi JH, Ahn MJ, Rhim HC, Kim JW, Lee GH, Lee YY, Kim IS

  • Cancer Res Treat.
  • 2005 Oct;37(5):290-293.
PURPOSE: This study compared the WHO criteria with the response evaluation criteria in solid tumors (RECIST) in the same patients with metastatic colorectal cancer in order to determine the significance...
Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil and Low Dose Leucovorin in Patients with Advanced Colorectal Cancer

Shin YM, Han HS, Lim SW, Kim BC, Cheoi KS, Eum YO, Kim ST, Lee KH

  • Cancer Res Treat.
  • 2005 Oct;37(5):284-289.
PURPOSE: The aim of this study was to evaluate the efficacy and tolerability of the oxaliplatin, 5-fluorouracil (5-FU) and low dose leucovorin (LV) combination in patients with advanced colorectal cancer....
Oxaliplatin with Biweekly Low Dose Leucovorin and Bolus and Continuous Infusion of 5-fluorouracil (Modified FOLFOX 4) as a Salvage Therapy for Patients with Advanced Gastric Cancer

Suh SH, Kwon HC, Jo JH, Cho YR, Seo BG, Lee DM, Kim SH, Kim JS, Kim HJ

  • Cancer Res Treat.
  • 2005 Oct;37(5):279-283.
PURPOSE: To determine the activity and the toxicity associated with a low dose regimen of leucovorin (LV) plus 5-fluorouracil (5-FU) combined with oxaliplatin every two weeks (modified FOLFOX 4) as...
Treatment Outcomes of Three-Dimensional Conformal Radiotherapy for Stage III Non-Small Cell Lung Cancer

Yeo SG, Cho MJ, Kim SY, Lim SP, Kim KH, Kim JS

  • Cancer Res Treat.
  • 2005 Oct;37(5):273-278.
PURPOSE: To evaluate the treatment outcomes of the three-dimensional conformal radiotherapy (3D-CRT), in conjunction with induction chemotherapy, for the treatment of stage III non-small cell lung cancer (NSCLC). MATERIALS AND...
Results of Curative Radiation Therapy with or without Chemotherapy for Stage III Unresectable Non-Small Cell Lung Cancer

Ahn SJ, Kim YC, Kim KS, Park KO, Chung WK, Nam TK, Nah BS, Song JY, Yoon MS

  • Cancer Res Treat.
  • 2005 Oct;37(5):268-272.
PURPOSE: We retrospectively analyzed the patients who received curative radiotherapy for unresectable stage III NSCLC to investigate the impact of chemotherapy. MATERIALS AND METHODS: From 1998 to 2001, the records...
Epstein-Barr Virus in Human Malignancy: A Special Reference to Epstein-Barr Virus associated Gastric Carcinoma

Chang MS, Kim WH

  • Cancer Res Treat.
  • 2005 Oct;37(5):257-267.
Epstein-Bar virus (EBV), a human herpesvirus, establishes a life-long persistent infection in 90~95% of human adult population worldwide. EBV is the etiologic agent of infectious mononucleosis, and EBV is associated...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: